• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年妇科中的雌激素 - 孕激素替代疗法。绝经后第三阶段生活的长期预防]

[Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].

作者信息

Lauritzen C

出版信息

Fortschr Med. 1996 May 30;114(15):187-90.

PMID:8767936
Abstract

On average, post-menopausal women still have one-third of their lives ahead of them. It must be considered a task for the physician through the prophylactic and therapeutic application of estrogen (gestagen) replacement to secure for these women as high a quality of life as possible. The positive effects of replacement treatment affect, for example, the cardiovascular system, the urogenital system, osteoporosis and cognitive and mental functions. An absolute indication for estrogen replacement is very pronounced climacteric symptomatology that negatively influences the patient's quality of life, further marked complaints resulting from atrophic changes to the urogenital system, and manifest osteoporosis at the time of the menopause. Over and beyond this, numerous additional indications for such treatment can be listed, with only few contraindications.

摘要

平均而言,绝经后女性仍有三分之一的人生。通过预防性和治疗性应用雌激素(孕激素)替代疗法,为这些女性确保尽可能高的生活质量,这必须被视为医生的一项任务。替代疗法的积极作用例如会影响心血管系统、泌尿生殖系统、骨质疏松以及认知和心理功能。雌激素替代疗法的绝对适应症是非常明显的更年期症状,这些症状对患者的生活质量产生负面影响,泌尿生殖系统萎缩性变化导致的进一步明显不适,以及绝经时明显的骨质疏松。除此之外,这种治疗还有许多其他适应症,而禁忌症很少。

相似文献

1
[Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].[老年妇科中的雌激素 - 孕激素替代疗法。绝经后第三阶段生活的长期预防]
Fortschr Med. 1996 May 30;114(15):187-90.
2
Prognostic features of menopausal and postmenopausal applicants for life insurance.更年期及绝经后寿险申请人的预后特征。
J Insur Med. 1996;28(1):27-34.
3
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.骨质疏松症的预防与管理:加拿大骨质疏松症协会科学咨询委员会的共识声明。3. 卵巢激素疗法对女性骨骼及骨骼外组织的影响。
CMAJ. 1996 Oct 1;155(7):929-34.
4
Comparative cardiovascular effects of different progestins in menopause.不同孕激素在绝经后对心血管系统的比较影响
Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56.
5
A practical guide to prescribing estrogen replacement therapy.雌激素替代疗法处方实用指南。
Int J Fertil Menopausal Stud. 1995 Sep-Oct;40(5):229-47.
6
Current trends in hormone replacement therapy.激素替代疗法的当前趋势
Saudi Med J. 2002 May;23(5):495-502.
7
Management of problems during menopause.更年期问题的管理。
Compr Ther. 1990 Feb;16(2):3-10.
8
[Estrogen substitution in the postmenopause--effect and compliance].绝经后雌激素替代疗法——疗效与依从性
Ther Umsch. 1994 Nov;51(11):767-72.
9
Clinical management of the menopausal woman.
Int J Fertil Menopausal Stud. 1993;38 Suppl 1:15-22.
10
A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.绝经后女性使用雌激素替代疗法或激素替代疗法的决策树:北美更年期协会的共识意见
Menopause. 2000 Mar-Apr;7(2):76-86.